These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 12688036)
1. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered]. MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036 [No Abstract] [Full Text] [Related]
2. [Cox-2 inhibitors in the focus. Rofecoxib as effective as the "classics"]. MMW Fortschr Med; 2001 Nov; 143(46):50-1. PubMed ID: 11759601 [No Abstract] [Full Text] [Related]
3. [80,000 patients with arthrosis treated. Coxib gets through a practice test, too]. MMW Fortschr Med; 2002 Oct; 144(41):60. PubMed ID: 12474372 [No Abstract] [Full Text] [Related]
4. Tailoring arthritis therapy in the wake of the NSAID crisis. Olsen NJ N Engl J Med; 2005 Jun; 352(25):2578-80. PubMed ID: 15972863 [No Abstract] [Full Text] [Related]
5. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart]. MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204 [No Abstract] [Full Text] [Related]
7. The coxibs, selective inhibitors of cyclooxygenase-2. FitzGerald GA; Patrono C N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855 [No Abstract] [Full Text] [Related]
8. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results]. Oliw E; Wollheim FA Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877 [No Abstract] [Full Text] [Related]
9. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex). Wynn RL Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547 [No Abstract] [Full Text] [Related]
10. Why don't we initiate more large simple randomized controlled trials? Wright JM CMAJ; 2003 Nov; 169(11):1170-1. PubMed ID: 14638653 [No Abstract] [Full Text] [Related]
11. COX-2 inhibitors--a lesson in unexpected problems. Drazen JM N Engl J Med; 2005 Mar; 352(11):1131-2. PubMed ID: 15713947 [No Abstract] [Full Text] [Related]
17. [Analgesic in osteoporosis. Why so conservative with dosage?]. Pfeifer M MMW Fortschr Med; 2002 Sep; 144(35-36):9. PubMed ID: 12380349 [No Abstract] [Full Text] [Related]
18. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs. Zhao SZ; Wentworth C; Burke TA; Makuch RW Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778 [TBL] [Abstract][Full Text] [Related]
19. Raising the safety bar--the FDA's coxib meeting. Okie S N Engl J Med; 2005 Mar; 352(13):1283-5. PubMed ID: 15800221 [No Abstract] [Full Text] [Related]
20. [Celebrex: confirmed effectiveness and safety (new data)]. Nasonov EL Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753 [No Abstract] [Full Text] [Related] [Next] [New Search]